Mega Lifesciences PCL (BKK: MEGA)

Mega Lifesciences PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	15,845	15,681	15,686	14,136	12,589	11,130
Other Revenue	36.9	34.41	40.64	36.67	23.61	33.93
Revenue	15,882	15,716	15,727	14,172	12,613	11,164
Revenue Growth (YoY)	2.85%	-0.07%	10.97%	12.36%	12.98%	8.56%
Cost of Revenue	8,140	8,586	8,647	8,225	7,603	6,551
Gross Profit	7,741	7,130	7,080	5,947	5,010	4,612
Selling, General & Admin	4,410	4,191	4,359	3,769	3,288	3,176
Operating Expenses	4,410	4,191	4,359	3,769	3,288	3,176
Operating Income	3,332	2,939	2,722	2,178	1,722	1,436
Interest Expense	-29.45	-31.25	-28.73	-28.28	-72.28	-65.15
Interest & Investment Income	74.56	60.69	39.82	10.03	11.94	15.46
Earnings From Equity Investments	0.08	0.07	0.18	-1.51	-45.52	-9.4
Currency Exchange Gain (Loss)	-1,235	-706.57	-138.16	118.52	18.11	-78.31
EBT Excluding Unusual Items	2,142	2,262	2,595	2,277	1,634	1,299
Merger & Restructuring Charges	-	-	-	-	-11.7	-
Pretax Income	2,142	2,262	2,595	2,277	1,623	1,299
Income Tax Expense	295.19	269.06	354.63	336.02	234.33	160.03
Earnings From Continuing Operations	1,846	1,993	2,240	1,941	1,388	1,139
Minority Interest in Earnings	-0.18	0.05	1.49	5.97	4.2	-0.01
Net Income	1,846	1,993	2,242	1,947	1,393	1,139
Net Income to Common	1,846	1,993	2,242	1,947	1,393	1,139
Net Income Growth	-3.80%	-11.10%	15.14%	39.79%	22.32%	-5.60%
Shares Outstanding (Basic)	873	872	872	872	872	871
Shares Outstanding (Diluted)	873	872	872	872	872	871
Shares Change (YoY)	-0.01%	-	-	-	0.12%	0.21%
EPS (Basic)	2.12	2.29	2.57	2.23	1.60	1.31
EPS (Diluted)	2.12	2.29	2.57	2.23	1.60	1.31
EPS Growth	-3.79%	-11.10%	15.14%	39.79%	22.18%	-5.95%
Free Cash Flow	1,702	1,652	1,692	2,575	1,395	966.6
Free Cash Flow Per Share	1.95	1.89	1.94	2.95	1.60	1.11
Dividend Per Share	1.600	1.600	1.600	1.380	0.900	0.720
Dividend Growth	-3.03%	0%	15.94%	53.33%	25.00%	1.41%
Gross Margin	48.74%	45.37%	45.02%	41.97%	39.72%	41.32%
Operating Margin	20.98%	18.70%	17.31%	15.37%	13.65%	12.86%
Profit Margin	11.62%	12.68%	14.25%	13.74%	11.04%	10.20%
Free Cash Flow Margin	10.72%	10.51%	10.76%	18.17%	11.06%	8.66%
EBITDA	3,594	3,146	2,917	2,378	1,909	1,590
EBITDA Margin	22.63%	20.02%	18.55%	16.78%	15.14%	14.24%
D&A For EBITDA	262.69	207.49	195.24	200.2	187.09	154.07
EBIT	3,332	2,939	2,722	2,178	1,722	1,436
EBIT Margin	20.98%	18.70%	17.31%	15.37%	13.65%	12.86%
Effective Tax Rate	13.78%	11.90%	13.67%	14.76%	14.44%	12.32%
Revenue as Reported	15,956	15,776	15,767	14,301	12,643	11,179
Advertising Expenses	-	1,323	1,266	1,052	930.15	924.91

Source: S&P Capital IQ. Standard template. Financial Sources.